Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Belite Bio, Inc - American Depositary Shares
(NQ:
BLTE
)
161.26
-3.19 (-1.94%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Belite Bio, Inc - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
Belite Bio Announces Registered Direct Offering of $15 Million
February 05, 2025
From
Belite Bio, Inc
Via
GlobeNewswire
Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
November 27, 2024
From
Lin BioScience, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
November 12, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Insights into Belite Bio's Upcoming Earnings
↗
November 11, 2024
Via
Benzinga
Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results
November 05, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
November 03, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting
October 14, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit
October 08, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
September 26, 2024
Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
September 17, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
Belite Bio Announces First Patient Dosed in Phase 2/3 DRAGON II Trial of Tinlarebant for the Treatment of Stargardt Disease
September 10, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in Three Upcoming Investor Conferences
September 03, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
September 01, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
BLTE Stock Earnings: Belite Bio Misses EPS for Q2 2024
↗
August 09, 2024
BLTE stock results show that Belite Bio missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
August 09, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
August 08, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results
August 05, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Present at the JonesHealthcare Seaside Summit
July 08, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
June 12, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
May 14, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
BLTE Stock Earnings: Belite Bio Misses EPS for Q1 2024
↗
May 14, 2024
BLTE stock results show that Belite Bio missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
May 08, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
May 06, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
May 06, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
May 01, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces $25 Million Registered Direct Offering
April 25, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
March 22, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
